Category: GeneSafe®

GeneSafe® is the first non-invasive prenatal test that screens for both de novo and inherited single-gene disorders. Current non-invasive prenatal tests screen for aneuploidies and microdeletions. PrenatalSafe® Karyo also screens for rare aneuploidies and segmental chromosome imbalances (gains and losses) in every chromosome in the fetal genome, providing karyotype-level insight.
GeneSafe® goes further.
Through cfDNA analysis from maternal plasma, it screens for several clinically significant and life-altering genetic disorders that are not screened for with current NIPT technology.
GeneSafe® involves 3 different levels of screening: Inherited, de novo and Complete.